A new three-in-one blood test developed by researchers at the Institute of Cancer Research can pick out men with advanced prostate cancer who are likely to benefit from treatment with PARP inhibitors. The test detects early signs of resistance and monitors cancer's evolution over time, allowing for timely adjustments to treatment.
Scientists at the Institute of Atmospheric Physics have developed a new parameter called potential deformation (PD) to diagnose heavy precipitation. PD is closely related to the occurrence and distribution of strong precipitation, with a correlation coefficient reaching up to 0.7.
A KAUST team has found that transition-metal carbides, known as MXenes, can trap sunlight energy to purify water through evaporation. The Ti3C2 MXene achieved 100% efficiency in converting light to heat, while other materials like carbon nanotubes and graphene also showed high efficiency.
Researchers from Queensland University of Technology found that airborne pseudomonas aeruginosa bacteria can remain viable in the air for up to 45 minutes after being expelled by human coughs and sneezes. This could have significant implications for infection control in hospitals, particularly for patients with cystic fibrosis.
The EHRA White Book provides comprehensive data on cardiac arrhythmia treatment, including device implantations and interventional procedures. The 2017 edition shows significant disparities in treatment across countries, with higher volumes of device implantations in Western and Northern countries.
A world's largest randomized controlled trial found acupuncture as effective as pain medicine in providing long-term relief for patients with considerable pain. Despite initial pain persistence, acupuncture was deemed a viable treatment option for those unable to take standard drugs due to medical conditions.